Purpose Triple therapy comprising a long-acting muscarinic antagonist, long-acting β 2 -agonist
and inhaled corticosteroid is recommended for patients with chronic obstructive …

Background Limited real‐world data exist on healthcare resource utilization (HCRU) and
associated costs of patients with heart failure (HF) with reduced ejection fraction (HFrEF) and …

Objectives Individuals with tuberous sclerosis complex (TSC) experience a wide range of
health impacts, including epileptic seizures, negatively impacting their health-related quality of …

Introduction Prophylactic treatment of severe hemophilia A is burdensome, requiring frequent
intravenous injections. Extended half-life (EHL) factor VIII replacement therapies offer …

Objective Despite the prevalence of osteoarthritis (OA) in England, few studies have examined
the health economic impact of chronic pain associated with OA. The aim of this study was …

Background Major depressive disorder (MDD) is a chronic recurrent or episodic psychiatric
illness that can be successfully treated with oral antidepressants, yet one-in-three patients do …

Objectives To quantify direct costs and healthcare resource utilisation (HCRU) associated
with acute COVID-19 in adults in England. Design Population-based retrospective cohort …

… Theo Tritton made substantial contributions to the design of the work, interpretation of data
and critical revision of the manuscript. Olivia Massey made substantial contributions to the …

Objective To create case definitions for confirmed COVID-19 diagnoses, COVID-19
vaccination status and three separate definitions of high risk of severe COVID-19, as well as to …

Purpose Treatment pathways of patients with chronic obstructive pulmonary disease (COPD)
receiving single-inhaler dual therapies remain unclear. We aimed to describe …